Zensar Technologies' board approved an internal merger of two US-based subsidiaries (Bridgeview Life Sciences, M3BI LLC) into its wholly-owned US subsidiary, Zensar Technologies Inc. This strategic move aims for greater business synergies, operational efficiencies, and unified control of their digital solutions.